MedPath

Examining the effectiveness of a digital psychological intervention in people with Multiple Sclerosis attending the Multiple Sclerosis Clinic at Royal North Shore Hospital.

Not Applicable
Recruiting
Conditions
Depression
Anxiety
Cognitive difficulties
Fatigue
Multiple Sclerosis
Disability
Mental Health - Depression
Mental Health - Anxiety
Neurological - Multiple sclerosis
Registration Number
ACTRN12622000670774
Lead Sponsor
Dr Milena Gandy
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
120
Inclusion Criteria

Inclusion criteria include: (a) Patient at the Royal North Shore Hospital Multiple Sclerosis Clinic with a confirmed diagnosis of Multiple Sclerosis; (b) experiencing difficulties with their emotional and/or cognitive health, (c) 18+ years of age, (d) living in Australia,

Exclusion Criteria

Exclusion criteria include (a) immediately suicidal or unable to keep themselves safe; (b) severe cognitive impairment (c) are unable to read and understand English (d) do not have access to the internet.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Depression symptoms will be assessed using the widely used validated Patient Health Questionnaire 9-Item (PHQ9) [Pre-treatment, mid-treatment (5 weeks post commencement), post-treatment (10 weeks postcommencement), 3-months post-treatment. The primary endpoint is post-treatment.];Anxiety symptoms will be assessed using the well-validated Generalized Anxiety Disorder Scale 7-Item (GAD-7)[Pre-treatment, mid-treatment (5 weeks post commencement), post-treatment (10 weeks postcommencement), 3-months post-treatment. The primary endpoint is post-treatment.];World Health Organization Disability Assessment Schedule 2.0 12-Item (WHODAS-12). This is a measure that assesses health and disability, which is applicable to a variety of disability domains, including neurological, mental, and chronic physical conditions[Pre-treatment, mid-treatment (5 weeks post commencement), post-treatment (10 weeks postcommencement), 3-months post-treatment. The primary endpoint is post-treatment.]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath